相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
Susanne Saussele et al.
BLOOD (2010)
Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase
Jiri Pavlu et al.
BLOOD (2010)
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2009)
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens
O. Sala-Torra et al.
BONE MARROW TRANSPLANTATION (2008)
Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia - Need for new response definitions?
Hagop Kantarjian et al.
CANCER (2008)
Chronic myeloid leukemia in 2007
Jolynn Sessions
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: Comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning
Inho Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy
Martin Weisser et al.
LEUKEMIA & LYMPHOMA (2007)
Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)
K. Ramasamy et al.
BONE MARROW TRANSPLANTATION (2006)
Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia
M. Krejci et al.
BONE MARROW TRANSPLANTATION (2006)
Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era
Andrew Grigg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?
J Goldman et al.
LEUKEMIA & LYMPHOMA (2006)
Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
BN Savani et al.
BONE MARROW TRANSPLANTATION (2005)
The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era:: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study
GJ Ruiz-Argüelles et al.
BONE MARROW TRANSPLANTATION (2005)
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
C Crawley et al.
BLOOD (2005)
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML
FR Kerbauy et al.
LEUKEMIA (2005)
Peripheral blood stem cell apheresis for allogeneic transplants:: Ibni Sina experience
M Arat et al.
TRANSFUSION AND APHERESIS SCIENCE (2004)
Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia
M Das et al.
BONE MARROW TRANSPLANTATION (2003)
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase
R Or et al.
BLOOD (2003)
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
M Mohty et al.
LEUKEMIA (2003)
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
C Junghanss et al.
BLOOD (2002)
Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results
D Gaziev et al.
BONE MARROW TRANSPLANTATION (2002)
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study
C Junghanss et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
The effect of G-CSF on lymphocyte subsets and CD34+cells in allogeneic stem cell transplantation
G Gürman et al.
TRANSFUSION AND APHERESIS SCIENCE (2001)
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies
G Gurman et al.
CYTOTHERAPY (2001)
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings
JH Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
分享论文
